Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition?
Background and Aims. Patients with hemodynamic instability need to receive intensive treatment as fluid replacement and vasoactive drugs. In the meantime, it is supposed to initiate nutritional therapy within 24 to 48 hours after admission to the intensive care unit (ICU), as an essential part of pa...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Critical Care Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2020/1095693 |
id |
doaj-6a84d08dd34f4c798ef51831e99737c9 |
---|---|
record_format |
Article |
spelling |
doaj-6a84d08dd34f4c798ef51831e99737c92020-11-25T02:52:04ZengHindawi LimitedCritical Care Research and Practice2090-13052090-13132020-01-01202010.1155/2020/10956931095693Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition?Luís Henrique Simões Covello0Marcella Giovana Gava-Brandolis1Melina Gouveia Castro2Martins Fidelis Dos Santos Netos3William Manzanares4Diogo Oliveira Toledo5Department of Critical Care of Barretos Cancer Hospital, Barretos, BrazilDepartment of Research of Hospital São Luis Itaim, São Paulo, BrazilDepartment of Education of Hospital Israelita Albert Einstein, São Paulo, BrazilDepartment of Science Information of Barretos Cancer Hospital, Barretos, BrazilDepartment of Critical Care, University Hospital of Universidad de la Republica (UDELAR), Montevideo, UruguayDepartment of Critical Care of Hospital Israelita Albert Einstein, São Paulo, BrazilBackground and Aims. Patients with hemodynamic instability need to receive intensive treatment as fluid replacement and vasoactive drugs. In the meantime, it is supposed to initiate nutritional therapy within 24 to 48 hours after admission to the intensive care unit (ICU), as an essential part of patient’s intensive care and better outcomes. However, there are many controversies tangential to the prescription of enteral nutrition (EN) concomitant to the use of vasopressor and its doses. In this way, the present study aimed to identify what the literature presents of evidence to guide the clinical practice concerning the safe dose of vasopressors for the initiation of nutritional therapy in critically ill patients. Methods. This review was carried out in PubMed, ProQuest, Web of Science, and Medline databases. The descriptors were used to perform the search strategy: Critical Care, Intensive Care Units, Vasoconstrictor Agents, and Enteral Nutrition. Inclusion criteria were patients of both genders, over 18 years of age, using vasoactive drugs, with the possibility of receiving EN therapy, and articles written in English, Portuguese, and Spanish. In addition, exclusion criteria were case reports, non-papers, and repeated papers. Results. 10 articles met our inclusion criteria. Conclusion. It was observed that there are many controversies about the supply of EN in critically ill patients using vasopressor, especially about the safe dose, and it was not possible to identify a cutoff value for the beginning therapy. Despite the drug doses, clinical signs are still the most important parameters in the evaluation of EN tolerance.http://dx.doi.org/10.1155/2020/1095693 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Luís Henrique Simões Covello Marcella Giovana Gava-Brandolis Melina Gouveia Castro Martins Fidelis Dos Santos Netos William Manzanares Diogo Oliveira Toledo |
spellingShingle |
Luís Henrique Simões Covello Marcella Giovana Gava-Brandolis Melina Gouveia Castro Martins Fidelis Dos Santos Netos William Manzanares Diogo Oliveira Toledo Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition? Critical Care Research and Practice |
author_facet |
Luís Henrique Simões Covello Marcella Giovana Gava-Brandolis Melina Gouveia Castro Martins Fidelis Dos Santos Netos William Manzanares Diogo Oliveira Toledo |
author_sort |
Luís Henrique Simões Covello |
title |
Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition? |
title_short |
Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition? |
title_full |
Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition? |
title_fullStr |
Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition? |
title_full_unstemmed |
Vasopressors and Nutrition Therapy: Safe Dose for the Outset of Enteral Nutrition? |
title_sort |
vasopressors and nutrition therapy: safe dose for the outset of enteral nutrition? |
publisher |
Hindawi Limited |
series |
Critical Care Research and Practice |
issn |
2090-1305 2090-1313 |
publishDate |
2020-01-01 |
description |
Background and Aims. Patients with hemodynamic instability need to receive intensive treatment as fluid replacement and vasoactive drugs. In the meantime, it is supposed to initiate nutritional therapy within 24 to 48 hours after admission to the intensive care unit (ICU), as an essential part of patient’s intensive care and better outcomes. However, there are many controversies tangential to the prescription of enteral nutrition (EN) concomitant to the use of vasopressor and its doses. In this way, the present study aimed to identify what the literature presents of evidence to guide the clinical practice concerning the safe dose of vasopressors for the initiation of nutritional therapy in critically ill patients. Methods. This review was carried out in PubMed, ProQuest, Web of Science, and Medline databases. The descriptors were used to perform the search strategy: Critical Care, Intensive Care Units, Vasoconstrictor Agents, and Enteral Nutrition. Inclusion criteria were patients of both genders, over 18 years of age, using vasoactive drugs, with the possibility of receiving EN therapy, and articles written in English, Portuguese, and Spanish. In addition, exclusion criteria were case reports, non-papers, and repeated papers. Results. 10 articles met our inclusion criteria. Conclusion. It was observed that there are many controversies about the supply of EN in critically ill patients using vasopressor, especially about the safe dose, and it was not possible to identify a cutoff value for the beginning therapy. Despite the drug doses, clinical signs are still the most important parameters in the evaluation of EN tolerance. |
url |
http://dx.doi.org/10.1155/2020/1095693 |
work_keys_str_mv |
AT luishenriquesimoescovello vasopressorsandnutritiontherapysafedosefortheoutsetofenteralnutrition AT marcellagiovanagavabrandolis vasopressorsandnutritiontherapysafedosefortheoutsetofenteralnutrition AT melinagouveiacastro vasopressorsandnutritiontherapysafedosefortheoutsetofenteralnutrition AT martinsfidelisdossantosnetos vasopressorsandnutritiontherapysafedosefortheoutsetofenteralnutrition AT williammanzanares vasopressorsandnutritiontherapysafedosefortheoutsetofenteralnutrition AT diogooliveiratoledo vasopressorsandnutritiontherapysafedosefortheoutsetofenteralnutrition |
_version_ |
1715365529226575872 |